NCT01844869View on ClinicalTrials.gov

An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Hematologic MalignanciesSolid Tumors
Interventions
DRUG

omacetaxine mepesuccinate

Trial Locations (1)

Unknown

Teva Investigational Site 38045, Amsterdam

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT01844869 - An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate | Biotech Hunter | Biotech Hunter